Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Given the recent influx of evidence suggesting a connection between the popular diabetes and weight loss drug, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), and various ocular adverse events, a new study aimed to investigate this potential association on a global scale
BMC Endocr Disord
Upon starting a weight loss medication, regular check-ins with your provider can be scheduled
It supports investigations into metabolic signaling, receptor-binding kinetics, and preclinical models of energy and glucose regulation
US$ 29.44
US$ 20.15
US$ 25.70
